Series A - ENSEM Therapeutics
Investment Firm
Overview
ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
Announced Date
Oct 23, 2023
Funding Type
Series A
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 Legend Star |
Round Details and Background
ENSEM Therapeutics raised $10000000 on 2023-10-23 in Series A
ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 06, 2022 |  Series A - ENSEM Therapeutics | 6 | - | 67.0M |
| Oct 23, 2023 | Series A - ENSEM Therapeutics | 3 | - | 10.0M |
Recent Activity
There is no recent news or activity for this profile.